Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Gentamicin sulfate
Drug ID BADD_D01017
Description Gentamicin is a bactericidal aminoglycoside that was discovered and isolated from _Micromonospora purpurea_ in 1963.[A234349] It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability.[A234339,A234354] Gentamicin is effective against both gram-positive and gram-negative organisms but is particularly useful for the treatment of severe gram-negative infections including those caused by _Pseudomonas aeruginosa_.[A233325,A234359,A234364] There is the added benefit of synergy when gentamicin is co-administered with other antibacterials such as beta-lactams.[A234364] This synergistic activity is not only important for the treatment of complex infections, but can also contribute to dose optimization and reduced adverse effects.[A234359,A234364] Although gentamicin is well-established and may be used in a variety of clinical applications, it is also associated with severe adverse effects including nephrotoxicity and ototoxicity which may limit its use.[A234369]
Indications and Usage For treatment of serious infections caused by susceptible strains of the following microorganisms: P. aeruginosa, Proteus species (indole-positive and indole-negative), E. coli, Klebsiella-Enterobactor-Serratia species, Citrobacter species and Staphylococcus species (coagulase-positive and coagulase-negative).
Marketing Status Prescription; Discontinued
ATC Code D06AX07; J01GB03; S01AA11; S02AA14; S03AA06
DrugBank ID DB00798
KEGG ID D01063
MeSH ID D005839
PubChem ID 44134730
TTD Drug ID D0L9UU
NDC Product Code 63187-163; 63187-560; 71205-333; 61919-106; 67630-0003; 0338-0507; 76420-137; 68788-7336; 17478-827; 52565-090; 0713-0682; 63187-764; 52584-010; 0338-0503; 53002-9291; 63187-873; 0713-0683; 48866-8256; 63323-010; 0395-8229; 0404-9866; 61314-633; 60592-301; 17478-284; 0409-1207; 71205-560; 52584-207; 38779-0632; 71872-7216; 51552-0775; 53002-9290; 17478-826; 24208-580; 50090-2333; 17478-283; 42513-0008; 68071-1513; 0404-9865; 45802-056; 68071-4827; 66267-971; 68071-4775; 61919-918; 60758-188; 55154-2392; 45865-672; 0338-0505; 0338-0511; 51927-1610; 13985-603; 45802-046; 70518-1323; 62991-1072; 0338-0509; 50090-4770; 53002-9292
Synonyms Gentamicins | Gentamycins | Garamycin | Gentacycol | Gentamicin Sulfate | Sulfate, Gentamicin | Gentamicin Sulfate (USP) | Gentavet | Genticin | G-Myticin | G Myticin | GMyticin | Gentamicin | Gentamycin
Chemical Information
Molecular Formula C21H45N5O11S
CAS Registry Number 1403-66-3
SMILES CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.OS(=O)(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
NecrosisSodium/potassium-transporting ATPase subunit alpha-1P05023T40800Not Available
Nephropathy toxicVariant-surface-glycoprotein phospholipase CP09194Not AvailableNot Available
Renal impairmentLysosomal Pro-X carboxypeptidaseP42785T20371Not Available
Renal impairmentDipeptidyl aminopeptidase-like protein 6P42658Not AvailableNot Available
Toxicity to various agents1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Q9NQ66T26846Not Available
Toxicity to various agentsPhospholipase A2P04054T31479Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Conjunctivitis11.01.06.012; 06.04.01.002--
Eye irritation06.04.05.003--Not Available
Hallucination19.10.02.002--
Hypersensitivity10.01.03.003--
Skin irritation23.03.04.009--Not Available
Thrombocytopenic purpura01.08.01.003; 23.06.01.007--Not Available
Conjunctival hyperaemia06.04.01.004--Not Available
Conjunctival disorder06.06.02.004--Not Available
Ulcerative keratitis10.02.01.021; 06.04.02.004--
The 1th Page    1    Total 1 Pages